CA2472088A1 - Dual inlet mixed-flow blood pump - Google Patents
Dual inlet mixed-flow blood pump Download PDFInfo
- Publication number
- CA2472088A1 CA2472088A1 CA002472088A CA2472088A CA2472088A1 CA 2472088 A1 CA2472088 A1 CA 2472088A1 CA 002472088 A CA002472088 A CA 002472088A CA 2472088 A CA2472088 A CA 2472088A CA 2472088 A1 CA2472088 A1 CA 2472088A1
- Authority
- CA
- Canada
- Prior art keywords
- flow
- blood
- pump
- mixed
- impeller
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 187
- 239000008280 blood Substances 0.000 title claims abstract description 187
- 230000009977 dual effect Effects 0.000 title description 2
- 230000007704 transition Effects 0.000 claims abstract description 6
- 230000017531 blood circulation Effects 0.000 claims description 25
- 238000004804 winding Methods 0.000 claims description 18
- 230000001154 acute effect Effects 0.000 claims 1
- 210000002216 heart Anatomy 0.000 description 38
- 230000000541 pulsatile effect Effects 0.000 description 21
- 238000013461 design Methods 0.000 description 19
- 206010018910 Haemolysis Diseases 0.000 description 16
- 230000008588 hemolysis Effects 0.000 description 16
- 210000001765 aortic valve Anatomy 0.000 description 15
- 210000005240 left ventricle Anatomy 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 238000005086 pumping Methods 0.000 description 10
- 206010019280 Heart failures Diseases 0.000 description 9
- 238000007914 intraventricular administration Methods 0.000 description 9
- 230000002861 ventricular Effects 0.000 description 8
- 230000033001 locomotion Effects 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000010008 shearing Methods 0.000 description 7
- 238000002054 transplantation Methods 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 208000034158 bleeding Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000035602 clotting Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000000709 aorta Anatomy 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000000004 hemodynamic effect Effects 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 206010007559 Cardiac failure congestive Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 241000272165 Charadriidae Species 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 208000009378 Low Cardiac Output Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000011304 dilated cardiomyopathy 1A Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000037183 heart physiology Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04D—NON-POSITIVE-DISPLACEMENT PUMPS
- F04D13/00—Pumping installations or systems
- F04D13/02—Units comprising pumps and their driving means
- F04D13/06—Units comprising pumps and their driving means the pump being electrically driven
- F04D13/0606—Canned motor pumps
- F04D13/064—Details of the magnetic circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
- A61M60/17—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart inside a ventricle, e.g. intraventricular balloon pumps
- A61M60/174—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart inside a ventricle, e.g. intraventricular balloon pumps discharging the blood to the ventricle or arterial system via a cannula internal to the ventricle or arterial system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A61M60/221—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having both radial and axial components, e.g. mixed flow pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/422—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being electromagnetic, e.g. using canned motor pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/802—Constructional details other than related to driving of non-positive displacement blood pumps
- A61M60/804—Impellers
- A61M60/806—Vanes or blades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/802—Constructional details other than related to driving of non-positive displacement blood pumps
- A61M60/818—Bearings
- A61M60/825—Contact bearings, e.g. ball-and-cup or pivot bearings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/873—Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/876—Implantable batteries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/88—Percutaneous cables
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04D—NON-POSITIVE-DISPLACEMENT PUMPS
- F04D1/00—Radial-flow pumps, e.g. centrifugal pumps; Helico-centrifugal pumps
- F04D1/04—Helico-centrifugal pumps
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04D—NON-POSITIVE-DISPLACEMENT PUMPS
- F04D3/00—Axial-flow pumps
- F04D3/02—Axial-flow pumps of screw type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Mechanical Engineering (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Computer Networks & Wireless Communication (AREA)
- External Artificial Organs (AREA)
Abstract
A mixed-flow blood pump presents features of both axial-flow and radial-flow pumps. This mixed-flow blood pump comprises a stationary housing structure defining at least one blood inlet, a blood outlet, and a blood conduit between the at least one blood inlet and the blood outlet, and a rotative impeller mounted in the blood conduit. The at least one blood inlet, the blood outlet, the blood conduit and the rotative impeller have respective structures and configurations that operate the mixed-flow blood pump at a given point of a maximum hydraulic efficiency curve relating a specific pump rotational speed and a specific pump diameter. This given point is located within a transition region of the maximum hydraulic efficiency curve between axial-flow and radial-flow pumps.
Description
TITLE OF THE INVENTION
DUAL INLET MIXED-FLOW BLOOD PUMP
FIELD OF THE INVENTION
The present invention relates to a mixed-flow blood pump displaying characteristics of both radial-flow and axial-flow pumps.
BACKGROUND OF THE INVENTION
The present specification mentions a number of references which are herein incorporated by reference.
In North America, heart related diseases are stilt the leading cause of death.
Among the causes of heart mortality are congestive heart failure, cardiomyopathy and cardiogenic shock. The incidence of congestive heart failure increases dramatically for people over 45 years of age. In addition, a large part of the population in North America is now entering this age group.
Thus, the people who will need treatment for these types of diseases comprise a larger segment of the population. Many complications related to congestive heart failure, including death, could be avoided and many years added to these persons' lives if proper treatments were available.
The types of treatment available for patients of heart failure depend on the extent and severity of the illness. Many patients can be cured with rest and drug therapy but there are still severe cases that require various heart surgery, including heart transplantation. Actually, the mortality rate for patients with cardiomyopathy who receive drug therapy is about 25.% within two years
DUAL INLET MIXED-FLOW BLOOD PUMP
FIELD OF THE INVENTION
The present invention relates to a mixed-flow blood pump displaying characteristics of both radial-flow and axial-flow pumps.
BACKGROUND OF THE INVENTION
The present specification mentions a number of references which are herein incorporated by reference.
In North America, heart related diseases are stilt the leading cause of death.
Among the causes of heart mortality are congestive heart failure, cardiomyopathy and cardiogenic shock. The incidence of congestive heart failure increases dramatically for people over 45 years of age. In addition, a large part of the population in North America is now entering this age group.
Thus, the people who will need treatment for these types of diseases comprise a larger segment of the population. Many complications related to congestive heart failure, including death, could be avoided and many years added to these persons' lives if proper treatments were available.
The types of treatment available for patients of heart failure depend on the extent and severity of the illness. Many patients can be cured with rest and drug therapy but there are still severe cases that require various heart surgery, including heart transplantation. Actually, the mortality rate for patients with cardiomyopathy who receive drug therapy is about 25.% within two years
2 and there still is some form of these diseases that cannot be treated medically. One of the last options that remain for these patients is heart transplantation. Unfortunately, according to the procurement agency UNOS
(United Network for Organ Sharing in the United States), the waiting list for heart transplantation grows at a rate of more than twice the number of heart donors.
Considering these facts, it appears imperative to offer alternative treatments to heart transplantation. The treatment should not only add to a recipient's longevity but also improve his quality of life. In this context, mechanical circulatory support through Ventricular Assist Devices (VAD) is a worthwhile alternative given the large deficiency in the number of available organ donors.
In the 1980's, successful experiments with mechanical hearts and VADs serving as a bridge to transplantation increased significantly. The accumulated knowledge in all aspects of patient care, device designs and related problems led to the use of VADs as permanent implants. Now, it appears appropriate to address the problem of end stage heart failure with permanent mechanical heart implants. Among the various mechanical support devices, axial-flow VADs with a projected life span of five to ten years provides a very interesting approach. It is estimated that eight thousand (8,000) patients per year in Canada and seventy-six thousand patients (76,000) per year in the United States could benefit from VADs.
In 1980, the National Heart, Lung and Blood Institute (NHLBI) of the United States defined the characteristics for an implantable VAD (Altieri, F.D. and Watson, J.T., 1987, "Implantable Ventricular Assist Systems", Artif Organs, Vol. 11, pp. 237-246). These characteristics include medical requirements including restoration of hemodynamic function (pressure and cardiac index) avoidance of hemolysis, prevention of clot formation, infection .and bleeding,
(United Network for Organ Sharing in the United States), the waiting list for heart transplantation grows at a rate of more than twice the number of heart donors.
Considering these facts, it appears imperative to offer alternative treatments to heart transplantation. The treatment should not only add to a recipient's longevity but also improve his quality of life. In this context, mechanical circulatory support through Ventricular Assist Devices (VAD) is a worthwhile alternative given the large deficiency in the number of available organ donors.
In the 1980's, successful experiments with mechanical hearts and VADs serving as a bridge to transplantation increased significantly. The accumulated knowledge in all aspects of patient care, device designs and related problems led to the use of VADs as permanent implants. Now, it appears appropriate to address the problem of end stage heart failure with permanent mechanical heart implants. Among the various mechanical support devices, axial-flow VADs with a projected life span of five to ten years provides a very interesting approach. It is estimated that eight thousand (8,000) patients per year in Canada and seventy-six thousand patients (76,000) per year in the United States could benefit from VADs.
In 1980, the National Heart, Lung and Blood Institute (NHLBI) of the United States defined the characteristics for an implantable VAD (Altieri, F.D. and Watson, J.T., 1987, "Implantable Ventricular Assist Systems", Artif Organs, Vol. 11, pp. 237-246). These characteristics include medical requirements including restoration of hemodynamic function (pressure and cardiac index) avoidance of hemolysis, prevention of clot formation, infection .and bleeding,
3 and minimisation of the anti-coagulation requirement. Further technical requirements include: small size, control mode, long life span (> 2 years), low heating, noise and vibration.
VADs can be used in several circumstances where a patient has poor hemodynamic functions (low cardiac output, low ejection fraction, low systolic pressure). Whatever the origin of the cardiac failure, the goal of the VAD is to help the heart in its pumping action. The VAD reduces the load on the heart by enhancing circulation, thus restoring the hemodynamic functions and providing improved end organ perfusion. Many current VAD devices can achieve these goals; however they are not optimal, and hemolysis and thrombus formation are still important problems requiring investigation.
In the 1970's, the first approach to the problem of mechanical support was to imitate as much as possible the heart physiology. This resulted in the development of several pulsatile devices, some of these initial designs being still in use. The first developments were pneumatically driven devices while a second generation of pumps was electrically actuated. In the 1990's, a new generation of pumps has emerged which addresses certain problems associated with previous devices (size and power consumption). These pumps are non-pulsatile devices divided into two main categories: radial-flow blood pumps, and axial-flow blood pumps.
In a non-pulsatile VAD, an impeller is enclosed in a housing and continuously rotates to produce a pumping action. The faster the rotation, the higher the blood flow. These devices are called non-pulsatile or continuous because they provide for a constant blood flow. Most axial-flow blood pumps operate around 10 000 RPM (Rotations Per Minute). However, in in-vivo conditions, there is a dynamic range (about 1000 RPM around the operating point) over
VADs can be used in several circumstances where a patient has poor hemodynamic functions (low cardiac output, low ejection fraction, low systolic pressure). Whatever the origin of the cardiac failure, the goal of the VAD is to help the heart in its pumping action. The VAD reduces the load on the heart by enhancing circulation, thus restoring the hemodynamic functions and providing improved end organ perfusion. Many current VAD devices can achieve these goals; however they are not optimal, and hemolysis and thrombus formation are still important problems requiring investigation.
In the 1970's, the first approach to the problem of mechanical support was to imitate as much as possible the heart physiology. This resulted in the development of several pulsatile devices, some of these initial designs being still in use. The first developments were pneumatically driven devices while a second generation of pumps was electrically actuated. In the 1990's, a new generation of pumps has emerged which addresses certain problems associated with previous devices (size and power consumption). These pumps are non-pulsatile devices divided into two main categories: radial-flow blood pumps, and axial-flow blood pumps.
In a non-pulsatile VAD, an impeller is enclosed in a housing and continuously rotates to produce a pumping action. The faster the rotation, the higher the blood flow. These devices are called non-pulsatile or continuous because they provide for a constant blood flow. Most axial-flow blood pumps operate around 10 000 RPM (Rotations Per Minute). However, in in-vivo conditions, there is a dynamic range (about 1000 RPM around the operating point) over
4 which the output flow is pulsatile. Since the native heart is still contracting, a pressure difference between the ventricle (inlet) and the aorta (outlet) is created. This pressure variation will produce a variation in the pump flow.
The range of rotational speed over which pulsatile flow occurs is small; at lower speed back flow is observed (in diastole) and at higher speed the load on the heart is reduced to zero. In the latter case, no pressure variation occurs resulting in non-pulsatile flow.
Many advantages are associated with the use of non-pulsatile VADs and they all have a strong impact on the physiology as well as on the clinical management. These advantages include:
Size:
Non-pulsatile VADs provide a much smaller volume than pulsatile VADs, around 25 cc for an axial-flow blood pump, and 100 cc for a radial-flow blood pump, compared to 150 cc and more for pulsatile devices. For the sake of comparison a complete axial-flow VAD is usually smaller than the graft used for pulsatile pump. The clinical impact is the possibility to use this type of VADs in small adults as well as in children. Also, the small dimensions allow for placement of the pump in a more orthotopic position; that is, in the thorax near the heart instead of the upper abdomen. This eliminates the use of long cannula passing through the diaphragm.
Furthermore, for axial-flow VADs, the shape and size can be selected allowing for placement of the VAD in an intra-ventricular position.
Powe r:
The electrical power required to drive a non-pulsatile VAD is lower than for pulsatile VADs.
Simplicity:
Non-pulsatile VADs are mechanically simpler than pulsatile VADs;
The range of rotational speed over which pulsatile flow occurs is small; at lower speed back flow is observed (in diastole) and at higher speed the load on the heart is reduced to zero. In the latter case, no pressure variation occurs resulting in non-pulsatile flow.
Many advantages are associated with the use of non-pulsatile VADs and they all have a strong impact on the physiology as well as on the clinical management. These advantages include:
Size:
Non-pulsatile VADs provide a much smaller volume than pulsatile VADs, around 25 cc for an axial-flow blood pump, and 100 cc for a radial-flow blood pump, compared to 150 cc and more for pulsatile devices. For the sake of comparison a complete axial-flow VAD is usually smaller than the graft used for pulsatile pump. The clinical impact is the possibility to use this type of VADs in small adults as well as in children. Also, the small dimensions allow for placement of the pump in a more orthotopic position; that is, in the thorax near the heart instead of the upper abdomen. This eliminates the use of long cannula passing through the diaphragm.
Furthermore, for axial-flow VADs, the shape and size can be selected allowing for placement of the VAD in an intra-ventricular position.
Powe r:
The electrical power required to drive a non-pulsatile VAD is lower than for pulsatile VADs.
Simplicity:
Non-pulsatile VADs are mechanically simpler than pulsatile VADs;
5 they do not require complex structures such as valves, diaphragms, blood sacs, vents or compliance chambers. Non-pulsatile continuous VADs are made of a simple motor to which is coupled an impeller contained in a housing. One important advantage of a simple mechanical design is its extended durability. Durability as long as five to ten years (Nose, Y., 1995a, "Can We Develop a Totally Implantable Rotary Blood Pump? ", Artificial Organs, Vol.
19, pp. 561-562; and Jarvik, R.K., 1995, "System Consideration Favoring Rotary Artificial Hearts with Blood-Immersed Bearing", Artificial Organs, Vol. 19, pp. 565-570) could be achieved with continuous VADs compared with two years for pulsatile VADs (Pierce, W.S., Sapirstein, J.S. and Pae, W.E., 1996, "Total Artificial Heart: From Bridge to Transplant to Permanent Use", Ann Thorac Surg, Vol. 61, pp. 342-346). In principle, this would allow not only to use a non-pulsatile VAD as a bridge to transplantation but also as long term mechanical support.
Hemolysis:
Hemolysis, or tearing of the red blood cells, can be estimated in vitro with a parameter called the Normalised Index of Hemolysis (NIH).
Infection:
Interestingly, the probability of infection is reduced with continuous VADs. This is due in large part to the transcutaneous vent of a
19, pp. 561-562; and Jarvik, R.K., 1995, "System Consideration Favoring Rotary Artificial Hearts with Blood-Immersed Bearing", Artificial Organs, Vol. 19, pp. 565-570) could be achieved with continuous VADs compared with two years for pulsatile VADs (Pierce, W.S., Sapirstein, J.S. and Pae, W.E., 1996, "Total Artificial Heart: From Bridge to Transplant to Permanent Use", Ann Thorac Surg, Vol. 61, pp. 342-346). In principle, this would allow not only to use a non-pulsatile VAD as a bridge to transplantation but also as long term mechanical support.
Hemolysis:
Hemolysis, or tearing of the red blood cells, can be estimated in vitro with a parameter called the Normalised Index of Hemolysis (NIH).
Infection:
Interestingly, the probability of infection is reduced with continuous VADs. This is due in large part to the transcutaneous vent of a
6 pulsatile VAD which is an open door for opportunist infections and therefore requires daily cleaning.
Patient Issues:
Non-pulsatile VADs require less maintenance allowing the patient a greater autonomy. Also, most patients with a VAD are discharged from the hospital and returned to a normal life after about a month.
Presently, because of the vent in pulsatile VADs, patients cannot take a bath or swim since water could enter the motor compartment. Continuous VADs are less restrictive and allow the patient to practice more activities.
Radial-flow blood pumps were first used in cardio-pulmonary bypass for heart surgery. Based on results obtained with the Bio-Medicus pump (Medtronic Bio-Medicus Inc., Eden Prarie, MN), several groups decided to develop much smaller radial-flow blood pumps so that they could be totally implantable. In radial-flow blood pumps, the rotation of the impeller produces a centrifugal force that drags blood from the inlet port on top to the outlet port at the bottom. To produce rotation of the impeller, the impeller is coupled to an electric motor. This coupling is made either (a) magnetically by means of permanent magnets located under the impeller and on the rotor of the motor or (b) mechanically by means of a shaft interposed between the impeller and the motor's rotor. Magnetically coupled devices generally show better functionality because no seal is required between the motor and the impeller shaft.
A problem related to radial-flow blood pumps is that although they are much smaller than pulsatile pumps, they are still too large to be totally implanted in a human thorax thus eliminating any intra-ventricular implantation.
Patient Issues:
Non-pulsatile VADs require less maintenance allowing the patient a greater autonomy. Also, most patients with a VAD are discharged from the hospital and returned to a normal life after about a month.
Presently, because of the vent in pulsatile VADs, patients cannot take a bath or swim since water could enter the motor compartment. Continuous VADs are less restrictive and allow the patient to practice more activities.
Radial-flow blood pumps were first used in cardio-pulmonary bypass for heart surgery. Based on results obtained with the Bio-Medicus pump (Medtronic Bio-Medicus Inc., Eden Prarie, MN), several groups decided to develop much smaller radial-flow blood pumps so that they could be totally implantable. In radial-flow blood pumps, the rotation of the impeller produces a centrifugal force that drags blood from the inlet port on top to the outlet port at the bottom. To produce rotation of the impeller, the impeller is coupled to an electric motor. This coupling is made either (a) magnetically by means of permanent magnets located under the impeller and on the rotor of the motor or (b) mechanically by means of a shaft interposed between the impeller and the motor's rotor. Magnetically coupled devices generally show better functionality because no seal is required between the motor and the impeller shaft.
A problem related to radial-flow blood pumps is that although they are much smaller than pulsatile pumps, they are still too large to be totally implanted in a human thorax thus eliminating any intra-ventricular implantation.
7 To overcome the above-mentioned problem related to radial-flow blood pumps, axial-flow ventricular assist blood pumps were developed. These axial-flow blood pumps can decrease the hemolysis rate by decreasing the time of exposure of the blood to friction forces and by reducing the intensity of these forces. Another interesting advantage is that axial-flow blood pumps are generally much smaller than radial-flow blood pumps.
The first commercially available axial-flow blood pump was the HemopumpT""
(Medtronic Inc. Minneapolis, MN) used as short term circulatory support.
Based on the good results obtained with this pump, several groups have initiated the development of totally implantable axial-flow VADs for long term use.
A few axial-flow VADs are presently under intensive development. Examples are: the Jarvik 2000T"", by the Texas Heart Institute (Houston, Texas);
MicroMed DeBakeyT"" by MicroMed Technology (also of Houston, Texas); and HeartMate IIT"", by Thoratec (Pleasanton, California). All of these groups have already started in-vivo experiments on animals and humans although they still perform in-vitro trials. An overview of the operation of these pumps is given hereinbelow.
Jarvik 2000T""
This axial-flow blood pump comprises two stators, one at the inflow and one at the outflow. These stators have two functions: they support the bearing shaft around which the impeller will rotate (middle part) and they modify the blood flow path. The inflow stator initiates the rotation of the flow so that the blade tip of the rotor does not create too much shear stress on the blood cells. The
The first commercially available axial-flow blood pump was the HemopumpT""
(Medtronic Inc. Minneapolis, MN) used as short term circulatory support.
Based on the good results obtained with this pump, several groups have initiated the development of totally implantable axial-flow VADs for long term use.
A few axial-flow VADs are presently under intensive development. Examples are: the Jarvik 2000T"", by the Texas Heart Institute (Houston, Texas);
MicroMed DeBakeyT"" by MicroMed Technology (also of Houston, Texas); and HeartMate IIT"", by Thoratec (Pleasanton, California). All of these groups have already started in-vivo experiments on animals and humans although they still perform in-vitro trials. An overview of the operation of these pumps is given hereinbelow.
Jarvik 2000T""
This axial-flow blood pump comprises two stators, one at the inflow and one at the outflow. These stators have two functions: they support the bearing shaft around which the impeller will rotate (middle part) and they modify the blood flow path. The inflow stator initiates the rotation of the flow so that the blade tip of the rotor does not create too much shear stress on the blood cells. The
8 outflow stator straightens the flow so that blood from the pump enters the blood stream with a generally axial-flow profile.
Permanent magnets are enclosed in the center of the impeller and two motor windings are located in the casing on each side of the rotor. This configuration constitutes a DC brushless motor; this is a simple and durable motor which minimises the number of mechanical parts. The power cable is connected directly to the DC
brushless motor controller to change motor speed.
To implant the device, the chest is opened by means of a left thoracotomy and no cardiopulmonary bypass is used. The pump axial outflow is anastomosed to the aorta with a DacronT"~ graft.
Then a ventriculotomy is made to insert the pump into the ventricle through a sewing ring attached to the apex.
Micromed DeBakeyT""
The Micromed DeBakeyT"" VAD is very similar to the Jarvik 2000T""
design. Indeed, this concept of VAD is based on a DC brushless motor with blood-immersed bearings, a central impeller and two fixed side pieces. The Micromed VAD is described in U.S. patent No. 5,527,159 (Bozeman, Jr. et al.) issued on June 18, 1996.
Blood enters on the left side and passes through a flow straightener preventing pre-rotation thereof. Then, the blood reaches the inducer/impeller; the inducer initiates rotation of blood before this blood reaches the impeller. However, it should be noted that the impeller produces the effective pumping action. Finally, a flow diffuser converts the tangential flow into an axial flow. The inducer comprises three blades and the impeller is provided with
Permanent magnets are enclosed in the center of the impeller and two motor windings are located in the casing on each side of the rotor. This configuration constitutes a DC brushless motor; this is a simple and durable motor which minimises the number of mechanical parts. The power cable is connected directly to the DC
brushless motor controller to change motor speed.
To implant the device, the chest is opened by means of a left thoracotomy and no cardiopulmonary bypass is used. The pump axial outflow is anastomosed to the aorta with a DacronT"~ graft.
Then a ventriculotomy is made to insert the pump into the ventricle through a sewing ring attached to the apex.
Micromed DeBakeyT""
The Micromed DeBakeyT"" VAD is very similar to the Jarvik 2000T""
design. Indeed, this concept of VAD is based on a DC brushless motor with blood-immersed bearings, a central impeller and two fixed side pieces. The Micromed VAD is described in U.S. patent No. 5,527,159 (Bozeman, Jr. et al.) issued on June 18, 1996.
Blood enters on the left side and passes through a flow straightener preventing pre-rotation thereof. Then, the blood reaches the inducer/impeller; the inducer initiates rotation of blood before this blood reaches the impeller. However, it should be noted that the impeller produces the effective pumping action. Finally, a flow diffuser converts the tangential flow into an axial flow. The inducer comprises three blades and the impeller is provided with
9 six blades. The three blades of the inducer co-extend with three associated blades of the impeller. Each blade of the impeller contains eight cylindrical permanent magnets. Finally, a winding is placed outside the pump to complete the motor assembly, and the rotor is supported by a pair of bearings.
HeartMate IIT""
This pump is similar to the Micromed DeBakeyT"~ and the Jarvik 2000T"~ pumps. It is placed next to the heart and is connected between the apex of the heart and the aorta. It is also a sealed bearing type pump and, accordingly, requires a purge system. This system has a second pump which injects 15 ml/day of sterile solution in the sealed area. A pump without purge system is now under development. Three animals have been supported for one month with the HeartMate IIT"" (Konishi, H., Antaki, J.F. et al., 1996b, "Long-term Animal Survival with an Implantable Axial Flow Pump as a Left Ventricular Assist Device", Artificial Organs, vol. 20, pp. 124-127). ' Other axial-flow blood pumps have been proposed. For example, U.S. patent No. 5,205,721 (Isaacson) issued on April 27, 1993 discloses an axial-flow blood pump having a hydrodynamically suspended rotor centrally positioned with respect to the stator. Hydrodynamic bearings are created by two spaces in which blood must flow to create the hydrodynamic support; this in turn produces shearing forces applied to the blood. In addition, Isaacson teaches three types of impeller blades.
U.S. patent No. 5,211,546 granted to Isaacson et al. on May 18, 1993 teaches an axial-flow blood pump which is similar to that of U.S. patent No.
5,205,721. A rotor is suspended radially by hydrodynamic bearings. In certain embodiments, a radially centered thrust bearing element is provided to stabilise rotation of the suspended rotor.
5 U.S. patent No. 5,290,227 (Pasque) granted on May 1St, 1994 proposes an axial-flow blood pump having a rotor assembly described generally as a hollowed-out cylinder provided with rotor vanes which extend from the inner surtace of the hollowed cylindrical rotor towards the central rotation axis of the rotor. This design generates two pumping zones inside the pump, one of
HeartMate IIT""
This pump is similar to the Micromed DeBakeyT"~ and the Jarvik 2000T"~ pumps. It is placed next to the heart and is connected between the apex of the heart and the aorta. It is also a sealed bearing type pump and, accordingly, requires a purge system. This system has a second pump which injects 15 ml/day of sterile solution in the sealed area. A pump without purge system is now under development. Three animals have been supported for one month with the HeartMate IIT"" (Konishi, H., Antaki, J.F. et al., 1996b, "Long-term Animal Survival with an Implantable Axial Flow Pump as a Left Ventricular Assist Device", Artificial Organs, vol. 20, pp. 124-127). ' Other axial-flow blood pumps have been proposed. For example, U.S. patent No. 5,205,721 (Isaacson) issued on April 27, 1993 discloses an axial-flow blood pump having a hydrodynamically suspended rotor centrally positioned with respect to the stator. Hydrodynamic bearings are created by two spaces in which blood must flow to create the hydrodynamic support; this in turn produces shearing forces applied to the blood. In addition, Isaacson teaches three types of impeller blades.
U.S. patent No. 5,211,546 granted to Isaacson et al. on May 18, 1993 teaches an axial-flow blood pump which is similar to that of U.S. patent No.
5,205,721. A rotor is suspended radially by hydrodynamic bearings. In certain embodiments, a radially centered thrust bearing element is provided to stabilise rotation of the suspended rotor.
5 U.S. patent No. 5,290,227 (Pasque) granted on May 1St, 1994 proposes an axial-flow blood pump having a rotor assembly described generally as a hollowed-out cylinder provided with rotor vanes which extend from the inner surtace of the hollowed cylindrical rotor towards the central rotation axis of the rotor. This design generates two pumping zones inside the pump, one of
10 these zones being an outer annulus which is expected to create substantial shearing of the blood in the outer part of the rotor.
European Patent No. EP 0 060 569 granted to Olson et al. on September 22"d, 1982 teaches a magnetically suspended and rotated impeller which comprises a bulky valve member which may be included as part of the impeller. Moreover, this European patent teaches impeller blades which axially extend outside of a shroud to connect to the valve member.
Pumps with impeller blades attached to a hollow cylindrical shaft, the shaft rotating around a fixed axle when a magnetic field is applied, reveal a secondary fluid flow path in the same direction as the primary path. A primary annular flow path is formed between the hollow shaft and the pump housing, and a secondary annular flow is formed between the hollow shaft and the supporting axle. However, these secondary annular paths have minimal flow rates and are used to insure proper lubrication of bearing faces or the cleaning of regions which would otherwise collect debris.
European Patent No. EP 0 060 569 granted to Olson et al. on September 22"d, 1982 teaches a magnetically suspended and rotated impeller which comprises a bulky valve member which may be included as part of the impeller. Moreover, this European patent teaches impeller blades which axially extend outside of a shroud to connect to the valve member.
Pumps with impeller blades attached to a hollow cylindrical shaft, the shaft rotating around a fixed axle when a magnetic field is applied, reveal a secondary fluid flow path in the same direction as the primary path. A primary annular flow path is formed between the hollow shaft and the pump housing, and a secondary annular flow is formed between the hollow shaft and the supporting axle. However, these secondary annular paths have minimal flow rates and are used to insure proper lubrication of bearing faces or the cleaning of regions which would otherwise collect debris.
11 SUMMARY OF THE INVENTION
The present invention relates to a mixed-flow blood pump presenting features of both axial-flow and radial-flow pumps. This mixed-flow blood pump comprises a stationary housing structure and a rotative impeller. The stationary housing structure defines at least one blood inlet, a blood outlet, and a blood conduit between these blood inlet and blood outlet, and the rotative impeller is mounted in the blood conduit. The at least one blood inlet, the blood outlet, the blood conduit and the rotative impeller have respective structures and configurations that operate the mixed-flow blood pump at a given point of a maximum hydraulic efficiency curve relating a specific pump rotational speed and a specific pump diameter, that given point being located within a transition region of the maximum hydraulic efficiency curve between axial-flow and radial-flow pumps.
Operating a mixed-flow blood pump, which presents the flow characteristics of an axial-flow blood pump while maintaining the throughput of a radial-flow blood pump, at the given point of the maximum hydraulic efficiency curve located within the transition region of the curve between radial-flow and axial-flow pumps enables obtention of a pumping efficiency as high as 53%.
The foregoing and other objects, advantages and features of the present invention will become more apparent upon reading of the following non-restrictive description of illustrative embodiments thereof, given by way of example only with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
In the appended drawings:
The present invention relates to a mixed-flow blood pump presenting features of both axial-flow and radial-flow pumps. This mixed-flow blood pump comprises a stationary housing structure and a rotative impeller. The stationary housing structure defines at least one blood inlet, a blood outlet, and a blood conduit between these blood inlet and blood outlet, and the rotative impeller is mounted in the blood conduit. The at least one blood inlet, the blood outlet, the blood conduit and the rotative impeller have respective structures and configurations that operate the mixed-flow blood pump at a given point of a maximum hydraulic efficiency curve relating a specific pump rotational speed and a specific pump diameter, that given point being located within a transition region of the maximum hydraulic efficiency curve between axial-flow and radial-flow pumps.
Operating a mixed-flow blood pump, which presents the flow characteristics of an axial-flow blood pump while maintaining the throughput of a radial-flow blood pump, at the given point of the maximum hydraulic efficiency curve located within the transition region of the curve between radial-flow and axial-flow pumps enables obtention of a pumping efficiency as high as 53%.
The foregoing and other objects, advantages and features of the present invention will become more apparent upon reading of the following non-restrictive description of illustrative embodiments thereof, given by way of example only with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
In the appended drawings:
12 Figure 1 is a cross sectional view of a human heart in which an illustrative intra-ventricular embodiment of the mixed-flow blood pump according to the present invention is installed;
Figure 2 is a graph showing, for different types of pumps, a curve relating a specific pump rotation speed NS with a specific pump diameter DS at the points where the pump is operating at maximum hydaulic efficiency;
Figure 3 is a side elevational view of the external shape of the illustrative intra-ventricular embodiment of the mixed-flow blood pump according to the present invention;
Figure 4a is a side elevational and cross sectional view of the illustrative intra-ventricular embodiment of the mixed-flow blood pump according to the present invention;
Figure 4b is a side elevational and cross sectional view of an illustrative extra-ventricular embodiment of the mixed-flow blood pump according to the present invention;
Figure 5a is an enlarged, partial side cross sectional view showing a first end mount of the drive shaft of the mixed-flow blood pump of Figure 4a or 4b;
Figure 5b is an enlarged, partial side cross sectional view showing a second end mount of the drive shaft of the mixed-flow blood pump of Figure 4a or 4b;
and Figure 6 is a schematic view of an illustrative embodiment of a VAD system
Figure 2 is a graph showing, for different types of pumps, a curve relating a specific pump rotation speed NS with a specific pump diameter DS at the points where the pump is operating at maximum hydaulic efficiency;
Figure 3 is a side elevational view of the external shape of the illustrative intra-ventricular embodiment of the mixed-flow blood pump according to the present invention;
Figure 4a is a side elevational and cross sectional view of the illustrative intra-ventricular embodiment of the mixed-flow blood pump according to the present invention;
Figure 4b is a side elevational and cross sectional view of an illustrative extra-ventricular embodiment of the mixed-flow blood pump according to the present invention;
Figure 5a is an enlarged, partial side cross sectional view showing a first end mount of the drive shaft of the mixed-flow blood pump of Figure 4a or 4b;
Figure 5b is an enlarged, partial side cross sectional view showing a second end mount of the drive shaft of the mixed-flow blood pump of Figure 4a or 4b;
and Figure 6 is a schematic view of an illustrative embodiment of a VAD system
13 implanted in a human being and comprising the mixed-flow blood pump of Figure 4a.
DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENT
In the following description, important aspects of the pump design are addressed. In particular, the pump design takes into consideration anatomical and physiological considerations combined with mechanical, electrical and material requirements. Finally, following this discussion, global characteristics of a VAD system are presented.
It should first be noted that the mixed-flow blood pump of the present invention is not restricted to an application to an implantable VAD system.
Since the mixed-flow blood pump according to the invention overcomes a number of drawbacks of the current blood pumps, those of ordinary skill in the art will understand that such a mixed-flow blood pump can be used as part of an intra-corporal system such as an intra-ventricular VAD, or an extra-ventricular VAD (for example a VAD located in the abdomen or thorax), or alternatively as a para-corporal or extra-corporal VAD (for example in a bridge to heart transplantation). It shall also be understood that the mixed-flow blood pump of the present invention can be used in temporary VADs (for example a bridge to heart transplant) or permanent VADs:
ANATOMICAL, PHYSIOLOGICAL AND SURGICAL CONSIDERATIONS
As previously discussed, bleeding is an important problem associated with patients who receive a VAD; in fact 30 % of patients suffer from this problem (Defraigne, J.O., Limet, R., 1996a, "Les assistances circulatoires: Partie I.
Indications et description des systemes", Rev Med Liege, Vol. 51, pp.295-
DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENT
In the following description, important aspects of the pump design are addressed. In particular, the pump design takes into consideration anatomical and physiological considerations combined with mechanical, electrical and material requirements. Finally, following this discussion, global characteristics of a VAD system are presented.
It should first be noted that the mixed-flow blood pump of the present invention is not restricted to an application to an implantable VAD system.
Since the mixed-flow blood pump according to the invention overcomes a number of drawbacks of the current blood pumps, those of ordinary skill in the art will understand that such a mixed-flow blood pump can be used as part of an intra-corporal system such as an intra-ventricular VAD, or an extra-ventricular VAD (for example a VAD located in the abdomen or thorax), or alternatively as a para-corporal or extra-corporal VAD (for example in a bridge to heart transplantation). It shall also be understood that the mixed-flow blood pump of the present invention can be used in temporary VADs (for example a bridge to heart transplant) or permanent VADs:
ANATOMICAL, PHYSIOLOGICAL AND SURGICAL CONSIDERATIONS
As previously discussed, bleeding is an important problem associated with patients who receive a VAD; in fact 30 % of patients suffer from this problem (Defraigne, J.O., Limet, R., 1996a, "Les assistances circulatoires: Partie I.
Indications et description des systemes", Rev Med Liege, Vol. 51, pp.295-
14 306). The risk of infection is another quite important problem. These medical and surgical considerations are met by the illustrative intra-ventricular embodiment of the mixed-flow blood pump as shown in Figure 1. This position eliminates the need for inflow and outflow grafts and their anastomoses to thereby reduce the risk of bleeding and infection. This has also the obvious advantage of considerably reducing the implantation time. Figure 1 illustrates the proposed position of the illustrative intra-ventricular embodiment of mixed-flow blood pump 2 in the left ventricle 4.
The mixed-flow blood pump 2 has also been designed to fit in small adults and in teens. Since the physical size and shape of the mixed-flow blood pump 2 are greatly influenced by the desired location of the pump, a good description of the ventricle anatomy is required. Feigenbaum, Harvey, "Echocardiography", 5th edition, 1994, Lea & Febiger, Philadelphia, presents several dimensions of the heart normalised by the BSA (Body Surface Area).
These anatomical dimensions have been statistically determined and are known to represent 95% of the population. Taking into consideration the above-identified statistics, a ventricular dimension for humans corresponding to a BSA of 1.5 m2 was used to design the pump.
It will be understood that the physical size and shape of the mixed-flow blood pump 2 could also be adapted to meet the anatomical dimensions of individuals falling outside this 95% of the population. Similarly, the size and shape could be adapted to specific and particular individuals and heart conditions.
For 95% of the population, the internal diameter of the left ventricle 4 ranges from 37 to 46 mm in diastole and between 22 to 31 mm in systole. This diameter is determined at the centre of the ventricular length (segment AB in Figure 1 ). The diameter near the apex at the first third of the ventricular length is about 1.5 cm (segment CD of Figure 1 ). The internal length of the ventricle from the apex to the aortic valve ranges from 55 to 70 mm. Finally, the other important parameter is the surface of the aortic valve opening which ranges 5 from 2.5 to 4 cm2.
From a surgical point of view, the favoured insertion procedure is to use the same approach as with valve replacement. According to this procedure, an incision is made at the root of the aorta 6 (Figure 1 ) and the mixed-flow blood 10 pump 2 is inserted though the aortic valve and then into the left ventricle 4.
The mixed-flow blood pump 2 is then pushed until its base reaches the myocardium at the apex 8. In order to prevent motion thereof, the mixed-flow blood pump 2 should be fixed. Also in accordance with an illustrative embodiment, an outflow cannula should pass through the aortic valve to
The mixed-flow blood pump 2 has also been designed to fit in small adults and in teens. Since the physical size and shape of the mixed-flow blood pump 2 are greatly influenced by the desired location of the pump, a good description of the ventricle anatomy is required. Feigenbaum, Harvey, "Echocardiography", 5th edition, 1994, Lea & Febiger, Philadelphia, presents several dimensions of the heart normalised by the BSA (Body Surface Area).
These anatomical dimensions have been statistically determined and are known to represent 95% of the population. Taking into consideration the above-identified statistics, a ventricular dimension for humans corresponding to a BSA of 1.5 m2 was used to design the pump.
It will be understood that the physical size and shape of the mixed-flow blood pump 2 could also be adapted to meet the anatomical dimensions of individuals falling outside this 95% of the population. Similarly, the size and shape could be adapted to specific and particular individuals and heart conditions.
For 95% of the population, the internal diameter of the left ventricle 4 ranges from 37 to 46 mm in diastole and between 22 to 31 mm in systole. This diameter is determined at the centre of the ventricular length (segment AB in Figure 1 ). The diameter near the apex at the first third of the ventricular length is about 1.5 cm (segment CD of Figure 1 ). The internal length of the ventricle from the apex to the aortic valve ranges from 55 to 70 mm. Finally, the other important parameter is the surface of the aortic valve opening which ranges 5 from 2.5 to 4 cm2.
From a surgical point of view, the favoured insertion procedure is to use the same approach as with valve replacement. According to this procedure, an incision is made at the root of the aorta 6 (Figure 1 ) and the mixed-flow blood 10 pump 2 is inserted though the aortic valve and then into the left ventricle 4.
The mixed-flow blood pump 2 is then pushed until its base reaches the myocardium at the apex 8. In order to prevent motion thereof, the mixed-flow blood pump 2 should be fixed. Also in accordance with an illustrative embodiment, an outflow cannula should pass through the aortic valve to
15 further reduce bleeding.
One of the main roles of the mixed-flow blood pump 2 is to restore a hemodynamic function in patients with cardiac failure. Depending on the severity of the failure and the BSA, the pump 2 is susceptible to work at flow rates between 2 to 6 litres per minute (I/min) against a pressure as high as 120 mmHg and, more commonly, at a flow rate between 3 to 5 I/min against a pressure of 80 mmHg.
Another important consideration for blood pump design is the hemolysis rate.
Hemolysis is the tearing of red blood cells which empties the content of the cells in the blood stream resulting in free haemoglobin; the normal level of plasma free haemoglobin is around 10 mg/dl. A blood pump with a normalised index of hemolysis (NIH) of 0.005 g/100 I and lower is considered to be almost athromatic for red blood cells. A NIH of about 0.05 g/100 I could be tolerated.
One of the main roles of the mixed-flow blood pump 2 is to restore a hemodynamic function in patients with cardiac failure. Depending on the severity of the failure and the BSA, the pump 2 is susceptible to work at flow rates between 2 to 6 litres per minute (I/min) against a pressure as high as 120 mmHg and, more commonly, at a flow rate between 3 to 5 I/min against a pressure of 80 mmHg.
Another important consideration for blood pump design is the hemolysis rate.
Hemolysis is the tearing of red blood cells which empties the content of the cells in the blood stream resulting in free haemoglobin; the normal level of plasma free haemoglobin is around 10 mg/dl. A blood pump with a normalised index of hemolysis (NIH) of 0.005 g/100 I and lower is considered to be almost athromatic for red blood cells. A NIH of about 0.05 g/100 I could be tolerated.
16 A NIH situated between 0.005 g/100 I to 0.05 g/100 I can therefore be envisaged for a VAD. Of course, a NIH as close to 0.005 g/100 I as possible is desirable.
Platelets are other important blood elements; their activation by high hydromechanical forces should be avoided in order to prevent clot formation.
MIXED-FLOW FLOW BLOOD PUMP DESIGN: Mechanical aspects This section of the disclosure is divided into parts A, B and C. Part A
describes the general approach used for the selection of the pump configuration. Part B describes the external shape and size of an illustrative embodiment of the mixed-flow blood pump according to the invention, and part C describes the internal structure of this illustrative embodiment of mixed-flow blood pump.
Part A: Selection of a general pump configuration There are three existing non-pulsatile pump configurations, all turbines, and having characteristics which make them potential candidates for a cardiac blood pump: radial-flow, axial-flow and mixed-flow pumps. Given their relatively small diameter, cylindrical shape and high throughput, axial-flow pumps display a number of characteristics which make them particularly well suited for implantation. However, other pump configurations also exhibit characteristics, different from those of the axial-flow pump, which would also be useful in a cardiac blood pump.
When designing turbine pumps, dimensionless characteristic values are used to compare different pump configurations. Dimensionless characteristic values
Platelets are other important blood elements; their activation by high hydromechanical forces should be avoided in order to prevent clot formation.
MIXED-FLOW FLOW BLOOD PUMP DESIGN: Mechanical aspects This section of the disclosure is divided into parts A, B and C. Part A
describes the general approach used for the selection of the pump configuration. Part B describes the external shape and size of an illustrative embodiment of the mixed-flow blood pump according to the invention, and part C describes the internal structure of this illustrative embodiment of mixed-flow blood pump.
Part A: Selection of a general pump configuration There are three existing non-pulsatile pump configurations, all turbines, and having characteristics which make them potential candidates for a cardiac blood pump: radial-flow, axial-flow and mixed-flow pumps. Given their relatively small diameter, cylindrical shape and high throughput, axial-flow pumps display a number of characteristics which make them particularly well suited for implantation. However, other pump configurations also exhibit characteristics, different from those of the axial-flow pump, which would also be useful in a cardiac blood pump.
When designing turbine pumps, dimensionless characteristic values are used to compare different pump configurations. Dimensionless characteristic values
17 provide useful indications to pump designers of expected performance regardless of the size of the pump, a comparison which would otherwise prove difficult given a virtually infinite number of operating parameters that depend on infinite variations of internal pump geometry. These dimensionless characteristic values, therefore, can be used to provide an objective starting point for the selection of a general pump configuration.
Two of these dimensionless characteristic values are the specific rotation .speed NS of the pump and the specific pump diameter DS. They are defined as follows:
Qaz H3/4 (1 ) D . Haa D.s - Qaz (2) where i~ is the rotation speed the pump in rad/s, Q is the flow rate in m3/second, H is the head (i.e. the gain in pressure) of the pump and D the diameter of the pump, both in meters. NS remains the same regardless of the size of the pump and therefore provides an accurate measure of the performance of a given pump design. DS relates the pump diameter to the pump head H and flow rate Q.
Referring to Figure 2, known are curves which relate the specific speed NS
with the specific diameter D$ at the points where the pump is operating at maximum hydraulic efficiency. In this regard, hydraulic efficiency is expressed as the percentage of the power input to the pump which is converted to energy of movement of the fluid within the pump. From the curve of Figure 2
Two of these dimensionless characteristic values are the specific rotation .speed NS of the pump and the specific pump diameter DS. They are defined as follows:
Qaz H3/4 (1 ) D . Haa D.s - Qaz (2) where i~ is the rotation speed the pump in rad/s, Q is the flow rate in m3/second, H is the head (i.e. the gain in pressure) of the pump and D the diameter of the pump, both in meters. NS remains the same regardless of the size of the pump and therefore provides an accurate measure of the performance of a given pump design. DS relates the pump diameter to the pump head H and flow rate Q.
Referring to Figure 2, known are curves which relate the specific speed NS
with the specific diameter D$ at the points where the pump is operating at maximum hydraulic efficiency. In this regard, hydraulic efficiency is expressed as the percentage of the power input to the pump which is converted to energy of movement of the fluid within the pump. From the curve of Figure 2
18 and equation (1) above, it follows that optimally efficient pumps having a higher specific speed also have a smaller size.
As referred to above, there are three (3) principal categories of non-pulsatile pumps characterised by the direction of flow of fluid through the puriip relative to the axis of rotation: axial-flow, radial-flow and mixed-flow pumps.
In axial-flow pumps the direction of fluid flow is parallel to the axis of rotation.
The pressure differential, or head, is produced by a change in the amount of tangential movement. Characteristics associated with axial-flow pumps include high flow rate Q and small head H. This results in high specific speeds NS.
In radial-flow pumps a large portion of the throughput, either on the outlet or the inlet, is radial, i.e. perpendicular to the axis of rotation. This change in direction causes an increase in pressure. Contrary to an axial-flow pump, a radial-flow pump is characterised by relatively large head H and smaller flow rate Q, resulting in lower specific speeds NS.
Located between radial-flow pumps and axial-flow pumps are mixed-flow pumps where the direction of flow at the output or input is composed of both radial-flow and axial-flow components. As would be expected, the specific speed of mixed-flow pumps is located between the specific speed of axial-flow and radial-flow pumps.
In order to determine an optimised choice for a pump, it is necessary to evaluate the specific speed NS in light of the characteristics in terms of head H and flow rate Q projected for the pump. As discussed above, the pump will typically be operated with a flow rate of 5 I/min and a head of approximately
As referred to above, there are three (3) principal categories of non-pulsatile pumps characterised by the direction of flow of fluid through the puriip relative to the axis of rotation: axial-flow, radial-flow and mixed-flow pumps.
In axial-flow pumps the direction of fluid flow is parallel to the axis of rotation.
The pressure differential, or head, is produced by a change in the amount of tangential movement. Characteristics associated with axial-flow pumps include high flow rate Q and small head H. This results in high specific speeds NS.
In radial-flow pumps a large portion of the throughput, either on the outlet or the inlet, is radial, i.e. perpendicular to the axis of rotation. This change in direction causes an increase in pressure. Contrary to an axial-flow pump, a radial-flow pump is characterised by relatively large head H and smaller flow rate Q, resulting in lower specific speeds NS.
Located between radial-flow pumps and axial-flow pumps are mixed-flow pumps where the direction of flow at the output or input is composed of both radial-flow and axial-flow components. As would be expected, the specific speed of mixed-flow pumps is located between the specific speed of axial-flow and radial-flow pumps.
In order to determine an optimised choice for a pump, it is necessary to evaluate the specific speed NS in light of the characteristics in terms of head H and flow rate Q projected for the pump. As discussed above, the pump will typically be operated with a flow rate of 5 I/min and a head of approximately
19 100 mmHg. Additionally, current motor technology provides small yet efficient motors operating at a speed of 11,000 RPM. This gives a specific speed of 1.62.
Referring again to Figure 2, an indication is given to the ranges of NS and DS
within which a given pump configuration will provide efficient operation. The specific speed NS of 1.62 falls within a transition region of the curve between axial-flow and radial-flow pumps. In this transition region, a mixed-flow pump topology would yield a higher efficiency than purely radial-flow or axial-flow pumps. Additionally, the specific diameter DS is around 2 which, by applying equation (2) above, yields a characteristic diameter of 9.83 X 10-3 for the pump, i.e. a very small pump.
Part B: External design requirements The external design (shape and size) of the mixed-flow blood pump 2 (Figure 1 ) depends on the anatomic dimensions of the left ventricle 4. Figure 3 illustrates the external shape of the mixed-flow blood pump 2 and the critical geometric parameters thereof.
Pump Inlets Figure 1 shows that the illustrative embodiment of the mixed-flow blood pump 2 rests at the bottom of the left ventricle 4, in the region of the apex 8 of the heart 30.
Referring to Figure 3, in order to prevent the inner walls of the left ventricle 4 from completely obstructing blood intake, two axially spaced apart inlets 12 and 14 are provided. Additionally, a first end of the pump presents the generaly configuration of a hemisphere 16. The diameter of the hemisphere 16 is set to approximately 20 mm, which is smaller than the segment CD (see Figure 1) and suitable to limit the level of pressure on the walls of the left ventricle 4 near the apex 8.
The inlet 12 is found at the first end of the pump 2 between the hemisphere 16 and a first end of an axial, cylindrical member 18. As illustrated in Figure 4, the cylindrical member 18 contains the stator windings 80. A first series of narrow, axially extending supports 20 spread out evenly around the axis of 10 the pump 2 connects the hemisphere 16 to the cylindrical member 18.
The second inlet 14 is formed between the second end of the cylindrical member 18 and an impeller housing 22. A second series of narrow, axially extending supports 24 spread out evenly around the axis of the pump 2 15 interconnects the cylindrical member 18 to the impeller housing 22. As can be seen, the second inlet 14 is axially spaced apart from the first inlet 12. The separation between the inlets 12 and 14 reduces the effect occlusion of one of the pump inlets may have on normal operation of the pump 2.
Referring again to Figure 2, an indication is given to the ranges of NS and DS
within which a given pump configuration will provide efficient operation. The specific speed NS of 1.62 falls within a transition region of the curve between axial-flow and radial-flow pumps. In this transition region, a mixed-flow pump topology would yield a higher efficiency than purely radial-flow or axial-flow pumps. Additionally, the specific diameter DS is around 2 which, by applying equation (2) above, yields a characteristic diameter of 9.83 X 10-3 for the pump, i.e. a very small pump.
Part B: External design requirements The external design (shape and size) of the mixed-flow blood pump 2 (Figure 1 ) depends on the anatomic dimensions of the left ventricle 4. Figure 3 illustrates the external shape of the mixed-flow blood pump 2 and the critical geometric parameters thereof.
Pump Inlets Figure 1 shows that the illustrative embodiment of the mixed-flow blood pump 2 rests at the bottom of the left ventricle 4, in the region of the apex 8 of the heart 30.
Referring to Figure 3, in order to prevent the inner walls of the left ventricle 4 from completely obstructing blood intake, two axially spaced apart inlets 12 and 14 are provided. Additionally, a first end of the pump presents the generaly configuration of a hemisphere 16. The diameter of the hemisphere 16 is set to approximately 20 mm, which is smaller than the segment CD (see Figure 1) and suitable to limit the level of pressure on the walls of the left ventricle 4 near the apex 8.
The inlet 12 is found at the first end of the pump 2 between the hemisphere 16 and a first end of an axial, cylindrical member 18. As illustrated in Figure 4, the cylindrical member 18 contains the stator windings 80. A first series of narrow, axially extending supports 20 spread out evenly around the axis of 10 the pump 2 connects the hemisphere 16 to the cylindrical member 18.
The second inlet 14 is formed between the second end of the cylindrical member 18 and an impeller housing 22. A second series of narrow, axially extending supports 24 spread out evenly around the axis of the pump 2 15 interconnects the cylindrical member 18 to the impeller housing 22. As can be seen, the second inlet 14 is axially spaced apart from the first inlet 12. The separation between the inlets 12 and 14 reduces the effect occlusion of one of the pump inlets may have on normal operation of the pump 2.
20 Oufiflow Cannula Referring back to Figures 1 and 3, at the second end of the mixed-flow blood pump 2, the outflow diameter 26 (see Figure 3) is reduced so as to reduce as much as possible the obstruction caused by an outflow cannula 28 to the operation of the aortic valve (not shown); since the function of the mixed-flow blood pump 2 is to assist blood circulation, blood flow contribution from the natural contraction of the heart 30 should be maintained. In an illustrative embodiment, the area of the outflow cannula 28, corresponding to diameter 26, is 1.3 cmZ.
21 As illustrated, the outflow cannula 28 is, in the illustrative embodiment, integral with the impeller housing 22.
As can be better seen from Figure 3, a blood diffuser 32 is formed at the free end of the cannula 28, integrally therewith. The function of the diffuser 32 is to reduce the shear stress on blood cells. Without diffuser 32, the velocity of blood ejected from the pump 2 is higher than the velocity of blood ejected from the heart 30. The difference in velocity between these two blood flows would result in shear stress proportional to this difference. Since the velocity is inversely proportional to the cross-sectional area, a solution for reducing the relative velocity of the blood flows from the pump 2 and from the heart 30 is (a) to increase the area of the orifice 34 of the cannula 28 to reduce the velocity of the flow of blood from the pump 2, and (b) to decrease the area occupied by the blood flow from the heart to increase the velocity of the latter blood flow. This is exactly the role of the diffuser 32. Of course, parameters such as the angle of opening and the length of the diffuser 32 can be adjusted at will to fit the mechanical characteristics of the pump 2 in view of minimising the shear stress on the blood cells.
Housing The diameter of the mixed-flow blood pump 2 is a compromise between pumping requirements and minimal interference with heart contraction. In an illustrative embodiment, the maximum allowable diameter 36 is about 22 mm which is the diameter of the left ventricle 4 in systole. This dimension is reasonable since people with heart failure generally have dilated ventricles.
The maximum length 38 of the mixed-flow blood pump 2, as illustrated in
As can be better seen from Figure 3, a blood diffuser 32 is formed at the free end of the cannula 28, integrally therewith. The function of the diffuser 32 is to reduce the shear stress on blood cells. Without diffuser 32, the velocity of blood ejected from the pump 2 is higher than the velocity of blood ejected from the heart 30. The difference in velocity between these two blood flows would result in shear stress proportional to this difference. Since the velocity is inversely proportional to the cross-sectional area, a solution for reducing the relative velocity of the blood flows from the pump 2 and from the heart 30 is (a) to increase the area of the orifice 34 of the cannula 28 to reduce the velocity of the flow of blood from the pump 2, and (b) to decrease the area occupied by the blood flow from the heart to increase the velocity of the latter blood flow. This is exactly the role of the diffuser 32. Of course, parameters such as the angle of opening and the length of the diffuser 32 can be adjusted at will to fit the mechanical characteristics of the pump 2 in view of minimising the shear stress on the blood cells.
Housing The diameter of the mixed-flow blood pump 2 is a compromise between pumping requirements and minimal interference with heart contraction. In an illustrative embodiment, the maximum allowable diameter 36 is about 22 mm which is the diameter of the left ventricle 4 in systole. This dimension is reasonable since people with heart failure generally have dilated ventricles.
The maximum length 38 of the mixed-flow blood pump 2, as illustrated in
22 Figure 2, is set in regard of the average distance between the apex 8 and the aortic valve 40 of the heart 30. In an illustrative embodiment, the length 38 of the mixed-flow blood pump 2 is about 55 mm. As shown in Figure 1, a reduction of the pump diameter (see 40) toward the outflow increases the aortic valve clearance in order to minimise interference with the aortic valve function.
Since in this illustrative embodiment the mixed-flow blood pump 2 will be completely located inside the left ventricle 4, blood will circulate around the pump 2. As a consequence, all external surfaces of the pump 2 should be as smooth as possible and avoid as much as possible abrupt deviations to thereby minimise vortices, turbulence and recirculation zones which may be at the origin of clot formation. To overcome this problem, the pump 2 and other components may be machined from surgical quality titanium.
Fixation Mechanism At the first end of the pump 2, a fixation mechanism 42 is provided. As an example, fixation mechanism 42 comprises:
- an elongated needle member 44 extending from the hemisphere 16, this needle member 44 being driven from the inside of the left ventricle 4 through the myocardium and the epicardium at the apex 8 of the heart 30;
and - a fixation disk 46 fastened to the free end of the needle member 44 on the outside of the heart 30 to firmly fix the mixed-flow blood pump 2 within the left ventricle 4.
Since in this illustrative embodiment the mixed-flow blood pump 2 will be completely located inside the left ventricle 4, blood will circulate around the pump 2. As a consequence, all external surfaces of the pump 2 should be as smooth as possible and avoid as much as possible abrupt deviations to thereby minimise vortices, turbulence and recirculation zones which may be at the origin of clot formation. To overcome this problem, the pump 2 and other components may be machined from surgical quality titanium.
Fixation Mechanism At the first end of the pump 2, a fixation mechanism 42 is provided. As an example, fixation mechanism 42 comprises:
- an elongated needle member 44 extending from the hemisphere 16, this needle member 44 being driven from the inside of the left ventricle 4 through the myocardium and the epicardium at the apex 8 of the heart 30;
and - a fixation disk 46 fastened to the free end of the needle member 44 on the outside of the heart 30 to firmly fix the mixed-flow blood pump 2 within the left ventricle 4.
23 Of course, it is within the scope of the present invention to employ any other type of fixation mechanism.
Electrical Supply The required electrical supply for the operation of the motor (to be described herein below) is made through a wire that could, for example, extend from the mixed-flow blood pump 2 along the needle member 44 to reach a controller and an energy source (both to be further described hereinafter).
Part C: Internal design characteristics In the design of the internal components, some of the characteristics of axial-flow pumps have been retained and combined with some of the characteristics of radial-flow pumps to form the mixed-flow blood pump 2.
Referring to Figure 4a, the mixed-flow blood pump 2 comprises a stationary housing structure comprising an inflow bushing mount 56 which defines the hemisphere 16, the cylindrical member 18, the impeller housing 22, a stationary outflow stator 52, an outflow bushing mount 58, the outflow cannula 28 and the blood diffuser 32. Blood pump 2 further comprises a rotative impeller 50 with an impeller shaft 48 and an impeller blade 70.
Current wet motor axial-flow blood pumps use permanent magnets inserted either in the central hub or in the impeller blades. Both methods require important compromises. Insertion of the permanent magnets in the central hub requires a large hub to locate the permanent magnets close to the motor windings for obvious electromagnetic coupling reasons. In contrast, a small hub has the advantage of increasing the pumped volume of blood. Insertion
Electrical Supply The required electrical supply for the operation of the motor (to be described herein below) is made through a wire that could, for example, extend from the mixed-flow blood pump 2 along the needle member 44 to reach a controller and an energy source (both to be further described hereinafter).
Part C: Internal design characteristics In the design of the internal components, some of the characteristics of axial-flow pumps have been retained and combined with some of the characteristics of radial-flow pumps to form the mixed-flow blood pump 2.
Referring to Figure 4a, the mixed-flow blood pump 2 comprises a stationary housing structure comprising an inflow bushing mount 56 which defines the hemisphere 16, the cylindrical member 18, the impeller housing 22, a stationary outflow stator 52, an outflow bushing mount 58, the outflow cannula 28 and the blood diffuser 32. Blood pump 2 further comprises a rotative impeller 50 with an impeller shaft 48 and an impeller blade 70.
Current wet motor axial-flow blood pumps use permanent magnets inserted either in the central hub or in the impeller blades. Both methods require important compromises. Insertion of the permanent magnets in the central hub requires a large hub to locate the permanent magnets close to the motor windings for obvious electromagnetic coupling reasons. In contrast, a small hub has the advantage of increasing the pumped volume of blood. Insertion
24 of the permanent magnets in the impeller blades yields a compromise since the geometry of the blades must be curved for pumping efficiency. As a consequence, some of the embedded magnets move away from the windings as the blades) curve(s).
In the approach proposed by the illustrative embodiment of the present invention, the mixed-flow blood pump 2 presents an enclosed-impeller mixed-flow configuration. In the illustrative intra-ventricular embodiment of this configuration as illustrated in Figure 4a, the impeller blade 70 is a spiralling auger-type impeller blade having a constant height and being rigidly attached to the outer surtace of the impeller drive shaft 48 and enclosed in the impeller housing 22. Obviously, the impeller blade 70 fits snugly withing the impeller housing 22. Of course, the shape (curvature and angulation) of the impeller blade 70 should be optimally designed in relation to pumping pertormance and other hydrodynamic considerations. In particular, the influence of the blade angulation on the level of shearing stresses, turbulence and cavitation responsible for red blood cell damage and increase of hemolysis rate must be carefully taken into consideration.
The end portion of the impeller shaft 48 bearing the impeller blade 70 is slightly tapered in a direction opposite to the direction of blood flow. This contributes to create the mixed-flow operation of the pump 2. More specifically, this slight taper imparts to the blood flow both axial and radial components.
Still referring to Figure 4a, at both ends of the impeller drive shaft 48 end pivots 66 and 68 protrude. The function of the end pivots 66 and 68 is to support the impeller drive shaft 48 at each end. The end pivots 66 and 68 are respectively inserted into the respective bushing mounts 56 and 58. Bushing 72 is mounted on the inner face of the inflow bushing mount 56. In the same manner, bushing 74 is mounted on the adjacent face of the outflow bushing mount 58. The bearings formed by the bushing and pivot assemblies 66;72 and 68;74 are the only mechanical parts subject to wear. Therefore, these 5 parts are expected to be mostly responsible for the life span of the mixed-flow blood pump 2.
Still referring to Figure 4a, the cylindrical gap 76 separating the impeller shaft 48 and the inner surface of the cylindrical member 18 should be sufficiently 10 thick to produce sufficient blood flow in order to increase washout and prevent clot formation. On the other hand, too large a gap 76 may either reduce the pump efficiency (by reducing the electromagnetic coupling) or result in higher hemolysis. Just a word to mention that the section of the impeller shaft 48 within the cylindrical member 18 is cylindrical whereby the gap 76 has a 15 constant thickness.
In the illustrative embodiment of Figures 1 and 4a, the volume of blood pumped through the second inlet 14 is typically 4 liters/minute. This is higher than the volume of blood pumped through the first inlet 12 and the cylindrical 20 gap 76 which is typically 1 liter/minute. A number of benefits is associated with the higher volume blood pumped through the second inlet 14. For example, installation of the mixed-flow blood pump 2 in the left ventricle 4 of a patient with the cannula 28 extending through the aortic valve generally interferes with proper operation of the aortic valve. Optimally, the aortic valve
In the approach proposed by the illustrative embodiment of the present invention, the mixed-flow blood pump 2 presents an enclosed-impeller mixed-flow configuration. In the illustrative intra-ventricular embodiment of this configuration as illustrated in Figure 4a, the impeller blade 70 is a spiralling auger-type impeller blade having a constant height and being rigidly attached to the outer surtace of the impeller drive shaft 48 and enclosed in the impeller housing 22. Obviously, the impeller blade 70 fits snugly withing the impeller housing 22. Of course, the shape (curvature and angulation) of the impeller blade 70 should be optimally designed in relation to pumping pertormance and other hydrodynamic considerations. In particular, the influence of the blade angulation on the level of shearing stresses, turbulence and cavitation responsible for red blood cell damage and increase of hemolysis rate must be carefully taken into consideration.
The end portion of the impeller shaft 48 bearing the impeller blade 70 is slightly tapered in a direction opposite to the direction of blood flow. This contributes to create the mixed-flow operation of the pump 2. More specifically, this slight taper imparts to the blood flow both axial and radial components.
Still referring to Figure 4a, at both ends of the impeller drive shaft 48 end pivots 66 and 68 protrude. The function of the end pivots 66 and 68 is to support the impeller drive shaft 48 at each end. The end pivots 66 and 68 are respectively inserted into the respective bushing mounts 56 and 58. Bushing 72 is mounted on the inner face of the inflow bushing mount 56. In the same manner, bushing 74 is mounted on the adjacent face of the outflow bushing mount 58. The bearings formed by the bushing and pivot assemblies 66;72 and 68;74 are the only mechanical parts subject to wear. Therefore, these 5 parts are expected to be mostly responsible for the life span of the mixed-flow blood pump 2.
Still referring to Figure 4a, the cylindrical gap 76 separating the impeller shaft 48 and the inner surface of the cylindrical member 18 should be sufficiently 10 thick to produce sufficient blood flow in order to increase washout and prevent clot formation. On the other hand, too large a gap 76 may either reduce the pump efficiency (by reducing the electromagnetic coupling) or result in higher hemolysis. Just a word to mention that the section of the impeller shaft 48 within the cylindrical member 18 is cylindrical whereby the gap 76 has a 15 constant thickness.
In the illustrative embodiment of Figures 1 and 4a, the volume of blood pumped through the second inlet 14 is typically 4 liters/minute. This is higher than the volume of blood pumped through the first inlet 12 and the cylindrical 20 gap 76 which is typically 1 liter/minute. A number of benefits is associated with the higher volume blood pumped through the second inlet 14. For example, installation of the mixed-flow blood pump 2 in the left ventricle 4 of a patient with the cannula 28 extending through the aortic valve generally interferes with proper operation of the aortic valve. Optimally, the aortic valve
25 should continue to function normally; however, in some cases, it has been observed that the aortic valve ceases to function further until it remains closed around the cannula 28. Typically, blood would have the tendency to collect in the region close to the aortic valve and the cannula 28 which might lead to thrombus formation and other adverse effects. The increased volume of blood
26 pumped through the second inlet 14 has the effect of creating turbulence in the region within the ventricle 4 bordered by the aortic valve and the cannula 28, thus providing improved washout of this region and thereby reducing the effects of the malfunctioning aortic valve.
On the one hand, the volume of blood pumped through the second inlet 14 contributes to the radial-flow operation of the mixed-flow blood pump 2. On the other hand, the volume of blood pumped through the first inlet 12 and the cylindrical gap 76 contributes to the axial-flow operation of the mixed-flow blood pump 2.
The stationary outflow stator 52 comprises a plurality of blades shaped and disposed around the outflow bushing mount 58 to transform the rotational motion of the flow about the longitudinal axis 54 into a translational motion.
Therefore, the stationary outflow stator 52 constitutes a blood flow straightener.
As previously mentioned, the pump design should minimise shearing stress in order to minimise hemolysis. In that context, reduction of the rotational speed would obviously contribute to reduce hemolysis. However, reduction of the rotational speed while pumping the same volume of blood requires an increase of the volume of blood contained in the rotor zone of the pump 2.
The volume of blood contained in the rotor zone can be increased by either increasing the diameter of the rotor zone, or alternatively minimising the volume of the central hub of the pump rotor.
Design of the internal surfaces of the pump is also important for minimising shearing stresses in order to minimise hemolysis. Figure 5a shows the configuration of the region between the inflow bushing mount 56 and the
On the one hand, the volume of blood pumped through the second inlet 14 contributes to the radial-flow operation of the mixed-flow blood pump 2. On the other hand, the volume of blood pumped through the first inlet 12 and the cylindrical gap 76 contributes to the axial-flow operation of the mixed-flow blood pump 2.
The stationary outflow stator 52 comprises a plurality of blades shaped and disposed around the outflow bushing mount 58 to transform the rotational motion of the flow about the longitudinal axis 54 into a translational motion.
Therefore, the stationary outflow stator 52 constitutes a blood flow straightener.
As previously mentioned, the pump design should minimise shearing stress in order to minimise hemolysis. In that context, reduction of the rotational speed would obviously contribute to reduce hemolysis. However, reduction of the rotational speed while pumping the same volume of blood requires an increase of the volume of blood contained in the rotor zone of the pump 2.
The volume of blood contained in the rotor zone can be increased by either increasing the diameter of the rotor zone, or alternatively minimising the volume of the central hub of the pump rotor.
Design of the internal surfaces of the pump is also important for minimising shearing stresses in order to minimise hemolysis. Figure 5a shows the configuration of the region between the inflow bushing mount 56 and the
27 impeller drive shaft 48. Figure 5b shows the configuration of the region between the impeller drive shaft 48 and the outflow bushing mount 58.
Referring to Figure 5a, the end surtace 60 of the impeller drive shaft 48 is convex and generally hemispheric while the confronting surface 62 of the bushing mount 56 is concave and generally hemispheric. Forming the surfaces in this manner reduces the shearing stress placed on the blood thus minimising hemolysis (see flow 61 ).
The outflow bushing mount 58 is formed with a similar convex, generally hemispheric end surface to reduce shearing stress at the outlet (see Figure 5b, in particular flow 65). The confronting end of the impeller shaft 48 is flat and perpendicular to the axis 54.
Additionally, referring to both Figures 5a and 5b, end pivots 66 and 68 by which the respective ends of the impeller shaft 48 are mounted to their respective bushing mounts 56, 58 are slightly tapered in a direction opposite to blood flow. This helps prevent the creation of eddies and the collection of debris in proximity to the end pivots. Normally, a taper of the order of five degrees (5°) is adequate.
In this manner, pivot 66 has a smaller diameter free end received within the bushing 72. In the same manner, the pivot 68 has a larger diameter free end received in the bushing 74.
Figure 4b illustrates an alternative, illustrative extra-ventricular embodiment of mixed-flow blood pump 100. Pump 100 is adapted for use externally of the heart as a ventricle bypass/assist. In this embodiment the pump 100 would typically be implanted above the diaphragm in the thorax and would be
Referring to Figure 5a, the end surtace 60 of the impeller drive shaft 48 is convex and generally hemispheric while the confronting surface 62 of the bushing mount 56 is concave and generally hemispheric. Forming the surfaces in this manner reduces the shearing stress placed on the blood thus minimising hemolysis (see flow 61 ).
The outflow bushing mount 58 is formed with a similar convex, generally hemispheric end surface to reduce shearing stress at the outlet (see Figure 5b, in particular flow 65). The confronting end of the impeller shaft 48 is flat and perpendicular to the axis 54.
Additionally, referring to both Figures 5a and 5b, end pivots 66 and 68 by which the respective ends of the impeller shaft 48 are mounted to their respective bushing mounts 56, 58 are slightly tapered in a direction opposite to blood flow. This helps prevent the creation of eddies and the collection of debris in proximity to the end pivots. Normally, a taper of the order of five degrees (5°) is adequate.
In this manner, pivot 66 has a smaller diameter free end received within the bushing 72. In the same manner, the pivot 68 has a larger diameter free end received in the bushing 74.
Figure 4b illustrates an alternative, illustrative extra-ventricular embodiment of mixed-flow blood pump 100. Pump 100 is adapted for use externally of the heart as a ventricle bypass/assist. In this embodiment the pump 100 would typically be implanted above the diaphragm in the thorax and would be
28 connected to the circulation system using standard vascular grafts, a first graft 102 being attached to the inflow end of the pump and a second graft 104 being attached to the outflow end of the pump 100.
Similar to the mixed-flow blood pump 2, the alternative illustrative embodiment 100 as illustrated in Figure 4b comprises a stationary housing structure including an inflow bushing mount 122, a cylindrical member 108, an impeller housing 106, a stationary outflow stator 114, an outflow bushing mount 124, an outflow cannula 150 and a blood diffuser 151. Blood pump 100 further comprises a rotative impeller 112 with an impeller shaft 110 and an impeller blade 116.
The impeller blade 116 is a spiralling auger-type impeller blade rigidly connected to the impeller drive shaft 110 and enclosed in the impeller housing 106.
A series of longitudinal ridges 118, typically five (5) evenly spaced around the pump axis 119, support the cylindrical member 108 within the impeller housing 106 thereby forming a series of longitudinal flow passages such as 120 between the cylindrical member 108 and the impeller housing 106.
The longitudinal ridges 118 extend to meet and hold rigid the inflow bushing mount 122 with respect to the impeller housing 106 and the cylindrical member 108. Similarly, the outflow bushing mount 124 is supported within the impeller housing 106 through the stationary outflow stator 114.
The stationary outflow stator 114 comprises a plurality of blades shaped and disposed around the outflow bushing mount 124 to transform the rotational motion of the blood flow about the longitudinal axis 119 into a translational
Similar to the mixed-flow blood pump 2, the alternative illustrative embodiment 100 as illustrated in Figure 4b comprises a stationary housing structure including an inflow bushing mount 122, a cylindrical member 108, an impeller housing 106, a stationary outflow stator 114, an outflow bushing mount 124, an outflow cannula 150 and a blood diffuser 151. Blood pump 100 further comprises a rotative impeller 112 with an impeller shaft 110 and an impeller blade 116.
The impeller blade 116 is a spiralling auger-type impeller blade rigidly connected to the impeller drive shaft 110 and enclosed in the impeller housing 106.
A series of longitudinal ridges 118, typically five (5) evenly spaced around the pump axis 119, support the cylindrical member 108 within the impeller housing 106 thereby forming a series of longitudinal flow passages such as 120 between the cylindrical member 108 and the impeller housing 106.
The longitudinal ridges 118 extend to meet and hold rigid the inflow bushing mount 122 with respect to the impeller housing 106 and the cylindrical member 108. Similarly, the outflow bushing mount 124 is supported within the impeller housing 106 through the stationary outflow stator 114.
The stationary outflow stator 114 comprises a plurality of blades shaped and disposed around the outflow bushing mount 124 to transform the rotational motion of the blood flow about the longitudinal axis 119 into a translational
29 motion. Therefore, the stationary outflow stator 114 constitutes a flow straightener.
At both ends of the impeller shaft 110 end pivots 126 and 128 protrude. The end pivots 126 and 128 are respectively inserted into respective bushings 130 and 132 to support the impeller drive shaft 110 within the cylindrical conduit 108 while at the same time allowing the impeller shaft 110 to rotate freely.
Bushing 130 is mounted on the inflow bushing mount 122. In the same manner, bushing 132 is mounted on the outflow bushing mount 124.
In addition to the series of longitudinal flow passages 120, an annular flow passage 134 is formed between the inner surface 136 of the cylindrical member 108 and the outer surface 138 of the impeller shaft 110.
Flow of blood through the mixed-flow pump 100 is indicated by the arrows 152-154.
The other characteristics of the mixed-flow pump 2 according to the illustrative embodiment of Figure 4a also apply to the illustrative embodiment 100 of Figure 4b.
Electrical Aspects In the illustrative embodiment of Figure 4a, the mixed-flow blood pump 2 is actuated by means of a brushless DC (direct current) motor. This brushless configuration presents the advantage of minimal wear. Two other interesting characteristics of brushless DC motors are high rotational speed and high torque.
In the mixed-flow blood pump 2, the brushless DC motor includes elongated axial permanent magnets such as 78 inserted in the impeller shaft 48 and stator windings 80 embedded or housed in the cylindrical member 18.
5 As discussed previously, the cylindrical gap 76 between the outer surface of the impeller shaft 48 and the inner surface of the cylindrical member 18 must be sufficiently thick to produce sufficient blood flow in order to increase washout and prevent clot formation. However, increasing the thickness of the gap 76 decreases the efficiency of the magnetic coupling between the 10 permanent magnets 78 and the stator windings 80. This requires an increase in current through the stator windings 80 to compensate for the decreased efficiency and to maintain the same characteristics in terms of impeller blade speed and blood volume throughput. Of course, increase in current leads to an increase in thermal loss from the stator windings 80; this thermal loss 15 increases as the square of the current through the stator windings 80. As the temperature of the surface of the stator windings must remain at or below 40°C, the gap 76 must be sufficiently small to provide efficient magnetic coupling between the permanent magnets 78 and the stator windings 80.
20 Thermal performance is also improved given the proximate position of the stator windings 80 to the external surface 82 of the cylindrical member 18.
Blood flow over the external surface 82 efficiently cools the stator windings 80. The flow of blood within the gap 76 between the impeller shaft 48 and the inner surface 84 of the cylindrical member 18 also contributes in efficiently 25 cooling the stator windings 80.
The alternative illustrative embodiment 100 of the mixed-flow blood pump as illustrated in Figure 4b maintains the essential electrical characteristics of the illustrative embodiment of Figure 4a with the exception that, referring to Figure 4b, the design of the pump 100 overcomes the thermal limitations by allowing for a second blood flow passage along the series of longitudinal flow passages 120 between the impeller housing 106 and the cylindrical member 108.
Axial spacing between the impeller blade and the permanent magnets along the impeller shaft enables separate design of the DC motor and the impeller to obtain simultaneously both efficient coupling between the permanent magnets and the stator windings and sufficient pumping volume.
Selection of the Materials The choice of materials for an implantable device is crucial and several properties of the available materials should be considered: strength, durability, hardness, elasticity, wear resistance, surface finish and biocompatibility.
Biocompatibility is very important to minimise irritation, rejection and thrombogenesis. The interaction between the surface of the material and the biological tissues is very complex. In several cases, treatment of the surface with human proteins, certain drugs like heparin or other biocompatible material may considerably increase the biocompatibility and minimise thrombus formation.
VAD SYSTEM
Figure 6 schematically illustrates an embodiment of implantable VAD system including an axial-flow blood pump 2. The VAD system is composed of four main parts:
- the axial-flow blood pump 2 implanted in the left ventricle 4 of the patient 86;
- an internal controller 88;
- two energy sources, namely an internal rechargeable battery 90 and an external rechargeable battery 92; and - a Transcutaneous Energy and Information Transmission (TEIT) system 94.
VAD and TEIT Systems are well known in the art and will not be further discussed in the present specification.
To conclude, ventricular assist devices (VADs) are now being used world-wide and their utilisation is becoming more and more accepted as a solution to treat end stage heart failure. It is generally accepted that VADs extend life of patients while improving quality of life of these patients. A poll, made with patients who received VADs, concerning their quality of life revealed that these patients would have preferred a heart transplant but prefer their situation than having to be on dialyses.
It is also now being accepted that VAD is becoming a cost effective solution considering the fact that patients are discharged from the hospitals more rapidly and may return to normal life occupations. In the United States, several insurance companies are now reimbursing the implantation of VADs.
Finally, the mixed-flow blood pump 2 according to the invention provides an excellent bridge to heart transplant and aims at long term implant. The new proposed mixed-flow blood pump 2 should answer most of the remaining problems and limitations of the prior axial-flow blood pumps, especially those related to hemolysis and bleeding.
Although the present invention has been described hereinabove by way of illustrative embodiments thereof, these embodiments can be modified at will;
within the scope of the appended claims, without departing from the spirit and nature of the present invention.
At both ends of the impeller shaft 110 end pivots 126 and 128 protrude. The end pivots 126 and 128 are respectively inserted into respective bushings 130 and 132 to support the impeller drive shaft 110 within the cylindrical conduit 108 while at the same time allowing the impeller shaft 110 to rotate freely.
Bushing 130 is mounted on the inflow bushing mount 122. In the same manner, bushing 132 is mounted on the outflow bushing mount 124.
In addition to the series of longitudinal flow passages 120, an annular flow passage 134 is formed between the inner surface 136 of the cylindrical member 108 and the outer surface 138 of the impeller shaft 110.
Flow of blood through the mixed-flow pump 100 is indicated by the arrows 152-154.
The other characteristics of the mixed-flow pump 2 according to the illustrative embodiment of Figure 4a also apply to the illustrative embodiment 100 of Figure 4b.
Electrical Aspects In the illustrative embodiment of Figure 4a, the mixed-flow blood pump 2 is actuated by means of a brushless DC (direct current) motor. This brushless configuration presents the advantage of minimal wear. Two other interesting characteristics of brushless DC motors are high rotational speed and high torque.
In the mixed-flow blood pump 2, the brushless DC motor includes elongated axial permanent magnets such as 78 inserted in the impeller shaft 48 and stator windings 80 embedded or housed in the cylindrical member 18.
5 As discussed previously, the cylindrical gap 76 between the outer surface of the impeller shaft 48 and the inner surface of the cylindrical member 18 must be sufficiently thick to produce sufficient blood flow in order to increase washout and prevent clot formation. However, increasing the thickness of the gap 76 decreases the efficiency of the magnetic coupling between the 10 permanent magnets 78 and the stator windings 80. This requires an increase in current through the stator windings 80 to compensate for the decreased efficiency and to maintain the same characteristics in terms of impeller blade speed and blood volume throughput. Of course, increase in current leads to an increase in thermal loss from the stator windings 80; this thermal loss 15 increases as the square of the current through the stator windings 80. As the temperature of the surface of the stator windings must remain at or below 40°C, the gap 76 must be sufficiently small to provide efficient magnetic coupling between the permanent magnets 78 and the stator windings 80.
20 Thermal performance is also improved given the proximate position of the stator windings 80 to the external surface 82 of the cylindrical member 18.
Blood flow over the external surface 82 efficiently cools the stator windings 80. The flow of blood within the gap 76 between the impeller shaft 48 and the inner surface 84 of the cylindrical member 18 also contributes in efficiently 25 cooling the stator windings 80.
The alternative illustrative embodiment 100 of the mixed-flow blood pump as illustrated in Figure 4b maintains the essential electrical characteristics of the illustrative embodiment of Figure 4a with the exception that, referring to Figure 4b, the design of the pump 100 overcomes the thermal limitations by allowing for a second blood flow passage along the series of longitudinal flow passages 120 between the impeller housing 106 and the cylindrical member 108.
Axial spacing between the impeller blade and the permanent magnets along the impeller shaft enables separate design of the DC motor and the impeller to obtain simultaneously both efficient coupling between the permanent magnets and the stator windings and sufficient pumping volume.
Selection of the Materials The choice of materials for an implantable device is crucial and several properties of the available materials should be considered: strength, durability, hardness, elasticity, wear resistance, surface finish and biocompatibility.
Biocompatibility is very important to minimise irritation, rejection and thrombogenesis. The interaction between the surface of the material and the biological tissues is very complex. In several cases, treatment of the surface with human proteins, certain drugs like heparin or other biocompatible material may considerably increase the biocompatibility and minimise thrombus formation.
VAD SYSTEM
Figure 6 schematically illustrates an embodiment of implantable VAD system including an axial-flow blood pump 2. The VAD system is composed of four main parts:
- the axial-flow blood pump 2 implanted in the left ventricle 4 of the patient 86;
- an internal controller 88;
- two energy sources, namely an internal rechargeable battery 90 and an external rechargeable battery 92; and - a Transcutaneous Energy and Information Transmission (TEIT) system 94.
VAD and TEIT Systems are well known in the art and will not be further discussed in the present specification.
To conclude, ventricular assist devices (VADs) are now being used world-wide and their utilisation is becoming more and more accepted as a solution to treat end stage heart failure. It is generally accepted that VADs extend life of patients while improving quality of life of these patients. A poll, made with patients who received VADs, concerning their quality of life revealed that these patients would have preferred a heart transplant but prefer their situation than having to be on dialyses.
It is also now being accepted that VAD is becoming a cost effective solution considering the fact that patients are discharged from the hospitals more rapidly and may return to normal life occupations. In the United States, several insurance companies are now reimbursing the implantation of VADs.
Finally, the mixed-flow blood pump 2 according to the invention provides an excellent bridge to heart transplant and aims at long term implant. The new proposed mixed-flow blood pump 2 should answer most of the remaining problems and limitations of the prior axial-flow blood pumps, especially those related to hemolysis and bleeding.
Although the present invention has been described hereinabove by way of illustrative embodiments thereof, these embodiments can be modified at will;
within the scope of the appended claims, without departing from the spirit and nature of the present invention.
Claims (18)
1. A mixed-flow blood pump presenting features of both axial-flow and radial-flow pumps, comprising:
a stationary housing structure defining a longitudinal axis, an axially-extending annular blood inlet passage, a radially-extending annular blood inlet passage, an axial blood outlet, and an axial blood conduit between (a) the axially-extending and radially-extending blood inlet passages, and (b) the axial blood outlet; and an rotative impeller mounted within the stationary housing structure, comprising:
an impeller shaft rotative about the longitudinal axis of the stationary housing structure, the impeller shaft having, in the axial blood conduit, a shaft portion tapered in a direction opposite to the direction of blood flow; and an impeller blade mounted on the tapered shaft portion;
- wherein the axially-extending annular blood inlet passage, the radially-extending annular blood inlet passage, the tapered shaft portion, the impeller blade mounted on the tapered shaft portion, and the axial blood outlet operate the mixed-flow blood pump at a given point of a maximum hydraulic efficiency curve relating a specific pump rotational speed and a specific pump diameter, said given point being located within a transition region of the maximum hydraulic efficiency curve between axial-flow and radial-flow pumps.
a stationary housing structure defining a longitudinal axis, an axially-extending annular blood inlet passage, a radially-extending annular blood inlet passage, an axial blood outlet, and an axial blood conduit between (a) the axially-extending and radially-extending blood inlet passages, and (b) the axial blood outlet; and an rotative impeller mounted within the stationary housing structure, comprising:
an impeller shaft rotative about the longitudinal axis of the stationary housing structure, the impeller shaft having, in the axial blood conduit, a shaft portion tapered in a direction opposite to the direction of blood flow; and an impeller blade mounted on the tapered shaft portion;
- wherein the axially-extending annular blood inlet passage, the radially-extending annular blood inlet passage, the tapered shaft portion, the impeller blade mounted on the tapered shaft portion, and the axial blood outlet operate the mixed-flow blood pump at a given point of a maximum hydraulic efficiency curve relating a specific pump rotational speed and a specific pump diameter, said given point being located within a transition region of the maximum hydraulic efficiency curve between axial-flow and radial-flow pumps.
2. A mixed-flow blood pump as defined in claim 1, wherein the specific pump rotation speed and, the specific pump diameter have dimensionless values.
3. A mixed-flow blood pump as defined in claim 2, wherein the dimensionless values of the specific pump rotational speed is 1.62.
4. A mixed-flow blood pump as defined in claim 1, wherein:
the stationary housing structure comprises first and second axially spaced apart annular blood inlets;
the axially-extending annular blood inlet passage extends between the first annular blood inlet and the axial blood conduit; and the radially-extending annular blood inlet passage extends between the second annular blood inlet and the axial blood conduit.
the stationary housing structure comprises first and second axially spaced apart annular blood inlets;
the axially-extending annular blood inlet passage extends between the first annular blood inlet and the axial blood conduit; and the radially-extending annular blood inlet passage extends between the second annular blood inlet and the axial blood conduit.
5. A mixed-flow blood pump as defined in claim 4, wherein:
the axially-extending annular blood inlet passage comprises a generally cylindrical axial passage portion.
the axially-extending annular blood inlet passage comprises a generally cylindrical axial passage portion.
6. A mixed-flow blood pump as defined in claim 4, wherein:
the radially-extending annular blood inlet passage defines an acute angle with respect to the longitudinal axis of the stationary housing.
the radially-extending annular blood inlet passage defines an acute angle with respect to the longitudinal axis of the stationary housing.
7. A mixed-flow blood pump as defined in claim 5, wherein:
the stationary housing structure comprises a cylindrical member with an inner surface; and the generally cylindrical, axial passage portion comprises a gap between the impeller shaft and the inner surface of the cylindrical member.
the stationary housing structure comprises a cylindrical member with an inner surface; and the generally cylindrical, axial passage portion comprises a gap between the impeller shaft and the inner surface of the cylindrical member.
8. A mixed-flow blood pump as defined in claim 1, in which the impeller blade comprise an auger-type impeller blade mounted on the impeller shaft.
9. A mixed-flow blood pump as defined in claim 1, wherein:
the stationary housing structure comprises a cylindrical member around the impeller shaft; and the mixed-flow blood pump further comprises an electrical motor structure comprising:
- permanent magnets embedded within the impeller shaft; and - electrical windings mounted within the cylindrical member of the stationary housing structure.
the stationary housing structure comprises a cylindrical member around the impeller shaft; and the mixed-flow blood pump further comprises an electrical motor structure comprising:
- permanent magnets embedded within the impeller shaft; and - electrical windings mounted within the cylindrical member of the stationary housing structure.
10. A mixed-flow blood pump as defined in claim 7, wherein:
the mixed-flow blood pump further comprises, in the region of the gap between the impeller shaft and the inner surface of the cylindrical member, an electrical motor structure comprising:
- permanent magnets embedded within the impeller shaft; and electrical windings mounted within the cylindrical member of the stationary housing structure.
the mixed-flow blood pump further comprises, in the region of the gap between the impeller shaft and the inner surface of the cylindrical member, an electrical motor structure comprising:
- permanent magnets embedded within the impeller shaft; and electrical windings mounted within the cylindrical member of the stationary housing structure.
11. A mixed-flow blood pump as defined in claim 1, wherein:
the impeller shaft comprises first and second opposite ends and first and second opposite end pivots; and the stationary housing structure comprises first and second bushing mounts at the respective first and second ends of the impeller shaft to receive the first and second opposite end pivots, respectively.
the impeller shaft comprises first and second opposite ends and first and second opposite end pivots; and the stationary housing structure comprises first and second bushing mounts at the respective first and second ends of the impeller shaft to receive the first and second opposite end pivots, respectively.
12. A mixed-flow blood pump as defined in claim 11, wherein:
the first pivot is slightly tapered in a direction opposite to the direction of blood flow and comprises a smaller diameter free end;
the first bushing mount comprises a first bushing to receive the smaller diameter free end of the first pivot;
the first bushing mount comprises a concave, generally hemispheric surface in the region of the first bushing; and the first end of the impeller shaft is convex and generally hemispheric.
the first pivot is slightly tapered in a direction opposite to the direction of blood flow and comprises a smaller diameter free end;
the first bushing mount comprises a first bushing to receive the smaller diameter free end of the first pivot;
the first bushing mount comprises a concave, generally hemispheric surface in the region of the first bushing; and the first end of the impeller shaft is convex and generally hemispheric.
13. A mixed-flow blood pump as defined in claim 11, wherein:
the second pivot is slightly tapered in a direction opposite to the direction of blood flow and comprises a larger diameter free end;
the second bushing mount comprises a second bushing to receive the larger diameter free end of the second pivot;
the second bushing mount comprises a convex, generally hemispheric surface in the region of the second bushing; and the second end of the impeller shaft is generally flat.
the second pivot is slightly tapered in a direction opposite to the direction of blood flow and comprises a larger diameter free end;
the second bushing mount comprises a second bushing to receive the larger diameter free end of the second pivot;
the second bushing mount comprises a convex, generally hemispheric surface in the region of the second bushing; and the second end of the impeller shaft is generally flat.
14. A mixed-flow blood pump as defined in claim 1, wherein:
the stationary housing structure comprises an impeller housing around the impeller blade, the impeller housing having an inner surface in which the impeller blade snugly fits.
the stationary housing structure comprises an impeller housing around the impeller blade, the impeller housing having an inner surface in which the impeller blade snugly fits.
15. A mixed-flow blood pump as defined in claim 11, wherein:
the impeller blade has a constant height.
the impeller blade has a constant height.
16. A mixed-flow blood pump as defined in claim 14, further comprising:
a flow straightener structure connected to the impeller housing for straightening the blood flow from the impeller blade; and a flow diffuser structure downstream the flow straightener structure to diffuse the straightened blood flow.
a flow straightener structure connected to the impeller housing for straightening the blood flow from the impeller blade; and a flow diffuser structure downstream the flow straightener structure to diffuse the straightened blood flow.
38 impeller comprises:
an impeller shaft with a shaft portion slightly tapered in a direction opposite to the direction of blood flow; and an impeller blade mounted on the slightly tapered portion of the impeller shaft.
an impeller shaft with a shaft portion slightly tapered in a direction opposite to the direction of blood flow; and an impeller blade mounted on the slightly tapered portion of the impeller shaft.
18. A mixed flow blood pump as defined in claim 5, wherein the impeller comprises:
an impeller shaft with a shaft portion slightly tapered in a direction opposite to the direction of blood flow; and an impeller blade mounted on the slightly tapered portion of the impeller shaft.
an impeller shaft with a shaft portion slightly tapered in a direction opposite to the direction of blood flow; and an impeller blade mounted on the slightly tapered portion of the impeller shaft.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002472088A CA2472088A1 (en) | 2002-03-08 | 2003-01-27 | Dual inlet mixed-flow blood pump |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2,374,989 | 2002-03-08 | ||
CA002374989A CA2374989A1 (en) | 2002-03-08 | 2002-03-08 | Ventricular assist device comprising a dual inlet hybrid flow blood pump |
CA002472088A CA2472088A1 (en) | 2002-03-08 | 2003-01-27 | Dual inlet mixed-flow blood pump |
PCT/CA2003/000103 WO2003075981A1 (en) | 2002-03-08 | 2003-01-27 | Dual inlet mixed-flow blood pump |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2472088A1 true CA2472088A1 (en) | 2003-09-18 |
Family
ID=32991609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002472088A Abandoned CA2472088A1 (en) | 2002-03-08 | 2003-01-27 | Dual inlet mixed-flow blood pump |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2472088A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014165993A1 (en) * | 2013-04-08 | 2014-10-16 | Harobase Innovations Inc. | Left ventricular cardiac assist pump and methods therefor |
CN111870751A (en) * | 2015-03-18 | 2020-11-03 | 阿比奥梅德欧洲股份有限公司 | Blood pump |
FR3130624A1 (en) * | 2021-12-21 | 2023-06-23 | Fineheart | Shrunken head intraventricular heart pump. |
CN116999688A (en) * | 2023-08-07 | 2023-11-07 | 安徽通灵仿生科技有限公司 | Impeller and right ventricle auxiliary device thereof |
-
2003
- 2003-01-27 CA CA002472088A patent/CA2472088A1/en not_active Abandoned
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014165993A1 (en) * | 2013-04-08 | 2014-10-16 | Harobase Innovations Inc. | Left ventricular cardiac assist pump and methods therefor |
US10420869B2 (en) | 2013-04-08 | 2019-09-24 | Systol Dynamics | Left ventricular cardiac assist pump and methods therefor |
CN111870751A (en) * | 2015-03-18 | 2020-11-03 | 阿比奥梅德欧洲股份有限公司 | Blood pump |
CN111870751B (en) * | 2015-03-18 | 2023-12-01 | 阿比奥梅德欧洲股份有限公司 | blood pump |
FR3130624A1 (en) * | 2021-12-21 | 2023-06-23 | Fineheart | Shrunken head intraventricular heart pump. |
WO2023117368A1 (en) * | 2021-12-21 | 2023-06-29 | Fineheart | Intraventricular cardiac pump with narrowed head |
CN116999688A (en) * | 2023-08-07 | 2023-11-07 | 安徽通灵仿生科技有限公司 | Impeller and right ventricle auxiliary device thereof |
CN116999688B (en) * | 2023-08-07 | 2024-05-14 | 安徽通灵仿生科技有限公司 | Impeller and right ventricle auxiliary device thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1485144B1 (en) | Dual inlet mixed-flow blood pump | |
US20070004959A1 (en) | Blood pump with frusto-conical bearing structure | |
WO1998053864A1 (en) | Ventricular assist device comprising an enclosed-impeller axial flow blood pump | |
US11185678B2 (en) | Blood pump | |
Reul et al. | Blood pumps for circulatory support | |
US9162018B2 (en) | Cardiac pump | |
US5290227A (en) | Method of implanting blood pump in ascending aorta or main pulmonary artery | |
AU678697B2 (en) | Cannula pumps for temporary cardiac support | |
US8790399B2 (en) | Total artificial heart system for auto-regulating flow and pressure balance | |
JPH1099429A (en) | Turbo-type blood pump | |
US20220296852A1 (en) | Mammalian body implantable fluid flow influencing device | |
Wampler et al. | A sealless centrifugal blood pump with passive magnetic and hydrodynamic bearings | |
Olia et al. | Preclinical performance of a pediatric mechanical circulatory support device: the PediaFlow ventricular assist device | |
CA2472088A1 (en) | Dual inlet mixed-flow blood pump | |
US20230211143A1 (en) | Left ventricle unloading device | |
CA2292432A1 (en) | Ventricular assist device comprising an enclosed-impeller axial flow blood pump | |
CA2517236A1 (en) | Blood pump with frusto-conical bearing structure | |
Golding et al. | Centrifugal pumps—now and the future | |
Benkowski et al. | Rotary blood pump | |
Kawahito et al. | Phase 1 ex vivo studies of the Baylor/NASA axial flow ventricular assist device | |
Nonaka et al. | The flexible inflow conduit for baylor gyro permanently implantable centrifugal blood pump as a biventricular assist device (BVAD) system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |